ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105023 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105023; 2) Community: the network communities that were significantly associated with the response to NSC 105023; 3) Molecule: the relationships between components within communities and NSC 105023; 4) MDR: the compounds that were significantly associated with the NSC 105023.

NSC Compound Enrichment Correlation
NSC 719715 Null 0.0342636096654271 0.20581889
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0342636096654271 0.25598759
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0342636096654271 0.24141976
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0342636096654271 0.25986073
NSC 728316 6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0342636096654271 0.56250846
NSC 733467 Null 0.0342636096654271 0.31025642
NSC 736802 Null 0.0342636096654271 0.45481267
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0342636096654271 0.29947274
NSC 740 Methotrexate 0.0342636096654271 0.52601834
NSC 743530 Null 0.0342636096654271 0.33060975
Total:121  Current:92    [First] [Prev] [Next] [Last]